Get the Full Picture of Your Patient’s Brain Health
Beyond GAL3: Analyze 8 Key SNPs to Optimize TB006 Treatment Decisions
Knowing LGALS3 Status Can Be Helpful – But Other Genetic Pathways
Also Play a Role
TB006 eligibility is just one piece of the puzzle. IntellxxDNA™ offers a broader genetic view that helps you optimize treatment strategies and long-term care.
✔ More than eligibility – Understand neuroinflammation, blood-brain barrier integrity, and other genetic markers affecting dementia.
✔ 8 SNPs analyzed – Provides a deeper look at genetic factors influencing TB006 response and overall brain health.
✔ Actionable results – Clinically relevant insights to support treatment decisions.
The IntellxxDNA™ Difference
EVIDENCE-BASED, PRECISION MEDICINE
The IntellxxDNA™ Clinical Decision Support Platform is a powerful, proprietary genomic research and intelligence platform, which provides comprehensive, accessible medical reporting and scientific explanations of an individual patient’s gene functions.
Our support of the clinical decision-making process helps to guide prevention and intervention strategies that enable cutting-edge, personalized medical and nutritional treatments.
Gain molecular-level insight into your patient’s state of well-being
Learn how to support your patient’s body using personalized nutrition, vitamins and supplements, as well as lifestyle changes to reduce the need for medications
Reduce frustration, time and money by using state-of-the-art advanced genomic technology to avoid unnecessary typical, trial and error approach to treatment
Your patients can Feel confident that their health care plan is being designed specifically for them.